RISA Labs has raised $3.5M to enhance its AI-powered oncology prior authorizations platform. This funding will help healthcare organizations tackle delays in cancer treatment caused by cumbersome workflows.
Amount Raised
$3.5 Million
Round Type
Seed
Investors
Description
RISA Labs has successfully secured $3.5M in funding to revolutionize oncology operations through AI-driven workflow orchestration. The funding aims to eliminate delays in prior authorizations that hinder timely access to cancer treatments. Founded by IIT Kanpur alumni, RISA is developing a systems-first approach to healthcare automation. Their innovative Business Operating System as a Service (BOSS) aims to streamline complex workflows in the healthcare sector.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as RISA Labs that raised within 45 days of this round, from Fundz verified event records.
- Outcomes4Me raised $21M on May 30, 2025.
- Skriber raised $1.3M (Seed) on May 23, 2025.
- Akido raised $60M (Series B) on May 15, 2025.
- PhaseV raised $50M (Series A) on May 13, 2025.
- Carta Healthcare raised $18M (Funding Round) on May 7, 2025.
- i'SUPPLY raised $3M (Seed) on May 6, 2025.
Who to call at RISA Labs, and when
A new round usually means RISA Labs is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RISA Labs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RISA Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RISA Labs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RISA Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
RISA Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.